Join us for a global CMT research convention, bringing together the research community and patients in a single event.
The CMT Research Foundation is laser-focused on delivering treatments and cures for Charcot-Marie-Tooth disease during our lifetime.
The 2021 Global CMT Research Convention unites researchers, pharma companies, government and patients to solve the most pressing problems in CMT drug development.
Come learn what the future holds for CMT and how you can help end the disease!
Thank you to the Muscular Dystrophy Association for their partnership in our first Global CMT Research Convention.
Interested in learning more?
The Scientific Programming Committee
Marina Kennerson, PhD – Chair
Professor of Neurogenetics and Neuroscience
ANZAC Research Institute and University of Sydney, Australia
Carla Taveggia, PhD – Vice Chair
Director, Division of Neuroscience
Ospedale San Raffaele, Milan, Italy
Charles Abrams, MD, PhD
Professor of Neurology and Rehabilitation
University of Illinois, Chicago (UIC)
Vice President of Biology
Robert Burgess, PhD
Professor, The Rare and Orphan Disease Center
The Jackson Laboratory
Amanda Haidet-Phillips, PhD
Senior Director, Translational Medicine
Novartis Gene Therapies
Program Director, Neurogenetics, Division of Neuroscience
U.S. National Institute of Neurological Disorders and Stroke (NINDS)
Jonathan Sabbagh, PhD
Scientific Portfolio Director
Muscular Dystrophy Association
Tiina Urv, PhD
Program Director, Office of Rare Diseases Research
U.S. National Center for Advancing Translational Sciences (NCATS)
Join us for this first opportunity to
unite the CMT community to end CMT!